Safety and Efficacy of FIT039 for Verruca Vulgaris: A Placebo-Controlled, Phase I/II Randomized Controlled Trial.
Nomura T, Sumi E, Egawa G, Nakajima S, Toichi E, Inoue N, Shibuya M, Okamoto N, Mitsuishi T, Uozumi R, Tada H, Nakagawa T, Kusuba N, Okuno A, Shimizuhira C, Ishikawa M, Tanaka S, Hagiwara M, Kabashima K.
Nomura T, et al. Among authors: shimizuhira c.
JID Innov. 2021 May 20;1(3):100026. doi: 10.1016/j.xjidi.2021.100026. eCollection 2021 Sep.
JID Innov. 2021.
PMID: 34909725
Free PMC article.
Clinical Trial.